These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
57 related items for PubMed ID: 5692860
1. In vitro antifungal activity of amphotericin B against Emmonsia crescens. Otcenásek M, Hubálek Z. Sabouraudia; 1968 Jun; 6(3):255-9. PubMed ID: 5692860 [No Abstract] [Full Text] [Related]
2. Antifungal activity of pyrithione against Emmonsia crescens in vitro and in vivo. Tomsíková A, Stĕrba J, Prokopic J, Novácková D. Folia Parasitol (Praha); 1982 Jun; 29(3):271-8. PubMed ID: 6890013 [Abstract] [Full Text] [Related]
3. [Susceptibility tests of Fonsecaea pedrosoi strains to the combination of thiabendazole and amphotericin B "in vitro"]. deRosanda MA. Rev Inst Med Trop Sao Paulo; 1979 Jun; 21(6):347-9. PubMed ID: 550289 [No Abstract] [Full Text] [Related]
4. [On the sensitivity of some yeasts to nystatin and amphotericin B]. Frágner P, Zajíková J. Cesk Epidemiol Mikrobiol Imunol; 1966 May; 15(3):185-90. PubMed ID: 4223604 [No Abstract] [Full Text] [Related]
5. [Experimental studies on the activity of pimaricin on Hendersonula toruloidea]. Wildfeuer A. Arzneimittelforschung; 1972 Jan; 22(1):101-4. PubMed ID: 4536875 [No Abstract] [Full Text] [Related]
6. Comparative effect of amphotericin B on Rhizoctonia sp., Paecilomyces lilacinus & Fusarium solani in vitro & in experimental keratitis. Wahab S, Tandon RN, Jacob Z, Srivastava OP, Pandey VC. Indian J Exp Biol; 1981 May; 19(5):458-61. PubMed ID: 6268532 [No Abstract] [Full Text] [Related]
7. [In vitro antifungal susceptibility of dematiaceous filamentous fungi using the E-test]. Vivas JR, Torres-Rodríguez JM. Rev Esp Quimioter; 2001 Jun; 14(2):191-7. PubMed ID: 11704774 [Abstract] [Full Text] [Related]
8. [Relationship between the spectral properties and antifungal properties of amphoterecin B and candicidine]. Coulon J, Lematre J, Bonaly R, Pierfitte M. Mycopathologia; 1980 May 01; 71(1):17-22. PubMed ID: 7189824 [Abstract] [Full Text] [Related]
9. [Effect of cyclosporin A and amphotericin B on protoplasts of Tolypocladium inflatum]. Sazukin IuO, Salova TV, Ivanov VP. Antibiot Khimioter; 1997 May 01; 42(3):3-5. PubMed ID: 9265464 [Abstract] [Full Text] [Related]
10. [Is amphotericin B active against dermatophytes and Scopulariopsis brevicaulis?]. Carrillo-Muñoz AJ, Santos P, del Valle O, Casals JB, Quindós G. Rev Esp Quimioter; 2004 Sep 01; 17(3):244-9. PubMed ID: 15619653 [Abstract] [Full Text] [Related]
11. Fungi associated with human corneal ulcers. Sandhu DK, Doodani A, Singh D. Mykosen; 1980 May 01; 23(5):269-73. PubMed ID: 6967560 [No Abstract] [Full Text] [Related]
12. Susceptibility of sequential Fonsecaea pedrosoi isolates from chromoblastomycosis patients to antifungal agents. Andrade TS, Castro LG, Nunes RS, Gimenes VM, Cury AE. Mycoses; 2004 Jun 01; 47(5-6):216-21. PubMed ID: 15189187 [Abstract] [Full Text] [Related]
13. The effect of amphotericin B on the fungal flora in feces. Bodey GP. Clin Pharmacol Ther; 1969 Jun 01; 10(5):675-80. PubMed ID: 5817629 [No Abstract] [Full Text] [Related]
14. [Antifungal susceptibility of yeasts by Etest. Comparison of 3 media]. Tapia C, León E, Palavecino E. Rev Med Chil; 2003 Mar 01; 131(3):299-302. PubMed ID: 12790079 [Abstract] [Full Text] [Related]
16. [Reproduction of Emmonsia crescens in vitro and in vivo]. Hejtmánek M, Kodousek R. Mykosen; 1971 Jun 01; 14(6):269-74. PubMed ID: 5212493 [No Abstract] [Full Text] [Related]
17. Fonsecaea pedrosoi: lipid composition and determination of susceptibility to amphotericin B. Gomes MH, Resende MA. Can J Microbiol; 1992 Mar 01; 38(3):209-14. PubMed ID: 1393822 [Abstract] [Full Text] [Related]
18. [Some mycologic and histologic data apropos of 2 cases of maduromycosis caue b Madurella grisea from the Caribbean Isles]. La Touche CJ, Tyagi SC, Gentles JC. Bull Soc Pathol Exot Filiales; 1967 Mar 01; 60(1):9-12. PubMed ID: 5631028 [No Abstract] [Full Text] [Related]
19. Serotonin (5-HT) enhances the activity of amphotericin B against Aspergillus fumigatus in vitro. Heller I, Leitner S, Dierich MP, Lass-Flörl C. Int J Antimicrob Agents; 2004 Oct 01; 24(4):401-4. PubMed ID: 15380269 [Abstract] [Full Text] [Related]
20. A new in-vitro kinetic model to study the pharmacodynamics of antifungal agents: inhibition of the fungicidal activity of amphotericin B against Candida albicans by voriconazole. Lignell A, Johansson A, Löwdin E, Cars O, Sjölin J. Clin Microbiol Infect; 2007 Jun 01; 13(6):613-9. PubMed ID: 17378925 [Abstract] [Full Text] [Related] Page: [Next] [New Search]